Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision [Yahoo! Finance]
CAPGEMINI SE UNSP/ADR (CGEMY)
NASDAQ:AMEX Investor Relations:
investors.capgemini.com
Company Research
Source: Yahoo! Finance
MIAMI and PERTH, Australia March 5, 2024 /PRNewswire/ -- Bridgewest Perth Pharma , a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced today the appointment of Mark W. Womack as a Director of the Board. "We are thrilled to have Mark join the Board, as a Director of the Company," said Dr. Masood Tayebi , Co-Founder and Chief Executive Officer of Bridgewest Group. "Mark has demonstrated his skills as both an entrepreneur and a visionary with multiple highly successful organizations, and we are excited to have his advice and wisdom at the Board level for Bridgewest Perth Pharma broadly, and more specifically NovaCina's commercial manufacturing of sterile injectables." Mark currently serves as CEO of BioCina, a Bridgewest Group funded CDMO providing end-to-end biologics solutions for microbial, pDNA and mRNA modalities globally. Prior to BioCina, as CEO of KBI Biopharma and Selexis SA, he spearheaded a run rate of over 30% YOY
Show less
Read more
Impact Snapshot
Event Time:
CGEMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CGEMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CGEMY alerts
High impacting CAPGEMINI SE UNSP/ADR news events
Weekly update
A roundup of the hottest topics
CGEMY
News
- France's Capgemini Q1 sales fall in slowing market [Reuters]Reuters
- Capgemini records Q1 2024 revenues of €5.5 billion in line with expectations [Yahoo! Finance]Yahoo! Finance
- France's Capgemini Q1 sales fall in slowing market [Yahoo! Finance]Yahoo! Finance
- What Is Cloud Provisioning? [Forbes]Forbes
- Lufax Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance